Factors that affect stabilisation times of canine spontaneous hypoadrenocorticism

The objective of this retrospective study was to examine factors that may have affected the stabilisation times of 50 dogs with spontaneous hypoadrenocorticism that were being treated with fludrocortisone acetate, with particular emphasis on dosing frequency and the concurrent use of prednisolone. S...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Veterinary record 2016-07, Vol.179 (4), p.98-98
Hauptverfasser: Roberts, E., Boden, L. A., Ramsey, I. K.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 98
container_issue 4
container_start_page 98
container_title Veterinary record
container_volume 179
creator Roberts, E.
Boden, L. A.
Ramsey, I. K.
description The objective of this retrospective study was to examine factors that may have affected the stabilisation times of 50 dogs with spontaneous hypoadrenocorticism that were being treated with fludrocortisone acetate, with particular emphasis on dosing frequency and the concurrent use of prednisolone. Stabilisation was defined as an absence of clinical signs with a sodium:potassium ratio >27:1 and both electrolyte concentrations within a laboratory reference range. It was found that the median time till stabilisation was three months. The frequency of fludrocortisone treatment (once, twice or changed from once to twice a day) had no effect on the stabilisation time. The two groups of dogs that were started and stabilised on once a day or twice a day dosing had a median stabilisation time of two months. However, dogs that failed to stabilise on once a day dosing of fludrocortisone and were then changed onto twice a day dosing then stabilised a median of one month later. Concurrent use of prednisolone resulted in significantly faster stabilisation times. It was concluded that dogs with hypoadrenocorticism should be continued on prednisolone therapy until they are stabilised. If a dog is failing to stabilise on once a day fludrocortisone acetate, a change to twice a day administration could be considered.
doi_str_mv 10.1136/vr.103663
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1811884919</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1807079618</sourcerecordid><originalsourceid>FETCH-LOGICAL-b4188-dc5f954e2de6ee542ba475baf2e859257416b6e41bae16f827d0e9bc1a7683043</originalsourceid><addsrcrecordid>eNqN0ctKxDAUBuAgio6XhS8gBV3oYjRJc2mWKo4KgijqtiTpKWZomzHJjMzb26HqQlBcJYsv_znhR2if4FNCcnG2CKcE50Lka2hEMaNjKSReRyO8ujOF8RbajnGKMVU8p5toi0oqFC3oCD1MtE0-xCy96pTpugabspi0cY2LOjnfZcm1EDNfZ1Z3roMsznyXdAd-HrPX5czrKkDnrQ_JWRfbXbRR6ybC3ue5g54nV0-XN-O7--vby_O7sWGkKMaV5bXiDGgFAoAzajST3OiaQsEV5ZIRYQQwYjQQURdUVhiUsURLUeSY5TvoeMidBf82h5jK1kULTTOsVpKC9HOYIuofFEsslSBFTw9_0Kmfh67_yEoJLnLKSa9OBmWDjzFAXc6Ca3VYlgSXq0rKRSiHSnp78Jk4Ny1U3_Krgx7QAby7Bpa_J5UvV0-PFxMilFrteTQ8Mu30j-Eff8-hEA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1806563251</pqid></control><display><type>article</type><title>Factors that affect stabilisation times of canine spontaneous hypoadrenocorticism</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Roberts, E. ; Boden, L. A. ; Ramsey, I. K.</creator><creatorcontrib>Roberts, E. ; Boden, L. A. ; Ramsey, I. K.</creatorcontrib><description>The objective of this retrospective study was to examine factors that may have affected the stabilisation times of 50 dogs with spontaneous hypoadrenocorticism that were being treated with fludrocortisone acetate, with particular emphasis on dosing frequency and the concurrent use of prednisolone. Stabilisation was defined as an absence of clinical signs with a sodium:potassium ratio &gt;27:1 and both electrolyte concentrations within a laboratory reference range. It was found that the median time till stabilisation was three months. The frequency of fludrocortisone treatment (once, twice or changed from once to twice a day) had no effect on the stabilisation time. The two groups of dogs that were started and stabilised on once a day or twice a day dosing had a median stabilisation time of two months. However, dogs that failed to stabilise on once a day dosing of fludrocortisone and were then changed onto twice a day dosing then stabilised a median of one month later. Concurrent use of prednisolone resulted in significantly faster stabilisation times. It was concluded that dogs with hypoadrenocorticism should be continued on prednisolone therapy until they are stabilised. If a dog is failing to stabilise on once a day fludrocortisone acetate, a change to twice a day administration could be considered.</description><identifier>ISSN: 0042-4900</identifier><identifier>EISSN: 2042-7670</identifier><identifier>DOI: 10.1136/vr.103663</identifier><identifier>PMID: 27269282</identifier><language>eng</language><publisher>England: BMJ Publishing Group Limited</publisher><subject>Adrenal gland ; Adrenal Insufficiency - drug therapy ; Adrenal Insufficiency - veterinary ; Adrenocortical Hyperfunction - drug therapy ; Adrenocortical Hyperfunction - veterinary ; Animals ; Dog Diseases - drug therapy ; Dogs ; Dose-Response Relationship, Drug ; Drug Therapy, Combination ; Endocrinology ; Female ; Fludrocortisone - therapeutic use ; Hormones ; Hyperkalemia ; Hyponatremia ; Male ; Potassium ; Prednisolone - therapeutic use ; Retrospective Studies ; Treatment Outcome</subject><ispartof>Veterinary record, 2016-07, Vol.179 (4), p.98-98</ispartof><rights>British Veterinary Association</rights><rights>British Veterinary Association 2013</rights><rights>British Veterinary Association.</rights><rights>Copyright: 2016 British Veterinary Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b4188-dc5f954e2de6ee542ba475baf2e859257416b6e41bae16f827d0e9bc1a7683043</citedby><cites>FETCH-LOGICAL-b4188-dc5f954e2de6ee542ba475baf2e859257416b6e41bae16f827d0e9bc1a7683043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1136%2Fvr.103663$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1136%2Fvr.103663$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27269282$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roberts, E.</creatorcontrib><creatorcontrib>Boden, L. A.</creatorcontrib><creatorcontrib>Ramsey, I. K.</creatorcontrib><title>Factors that affect stabilisation times of canine spontaneous hypoadrenocorticism</title><title>Veterinary record</title><addtitle>Vet Rec</addtitle><description>The objective of this retrospective study was to examine factors that may have affected the stabilisation times of 50 dogs with spontaneous hypoadrenocorticism that were being treated with fludrocortisone acetate, with particular emphasis on dosing frequency and the concurrent use of prednisolone. Stabilisation was defined as an absence of clinical signs with a sodium:potassium ratio &gt;27:1 and both electrolyte concentrations within a laboratory reference range. It was found that the median time till stabilisation was three months. The frequency of fludrocortisone treatment (once, twice or changed from once to twice a day) had no effect on the stabilisation time. The two groups of dogs that were started and stabilised on once a day or twice a day dosing had a median stabilisation time of two months. However, dogs that failed to stabilise on once a day dosing of fludrocortisone and were then changed onto twice a day dosing then stabilised a median of one month later. Concurrent use of prednisolone resulted in significantly faster stabilisation times. It was concluded that dogs with hypoadrenocorticism should be continued on prednisolone therapy until they are stabilised. If a dog is failing to stabilise on once a day fludrocortisone acetate, a change to twice a day administration could be considered.</description><subject>Adrenal gland</subject><subject>Adrenal Insufficiency - drug therapy</subject><subject>Adrenal Insufficiency - veterinary</subject><subject>Adrenocortical Hyperfunction - drug therapy</subject><subject>Adrenocortical Hyperfunction - veterinary</subject><subject>Animals</subject><subject>Dog Diseases - drug therapy</subject><subject>Dogs</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Therapy, Combination</subject><subject>Endocrinology</subject><subject>Female</subject><subject>Fludrocortisone - therapeutic use</subject><subject>Hormones</subject><subject>Hyperkalemia</subject><subject>Hyponatremia</subject><subject>Male</subject><subject>Potassium</subject><subject>Prednisolone - therapeutic use</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><issn>0042-4900</issn><issn>2042-7670</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqN0ctKxDAUBuAgio6XhS8gBV3oYjRJc2mWKo4KgijqtiTpKWZomzHJjMzb26HqQlBcJYsv_znhR2if4FNCcnG2CKcE50Lka2hEMaNjKSReRyO8ujOF8RbajnGKMVU8p5toi0oqFC3oCD1MtE0-xCy96pTpugabspi0cY2LOjnfZcm1EDNfZ1Z3roMsznyXdAd-HrPX5czrKkDnrQ_JWRfbXbRR6ybC3ue5g54nV0-XN-O7--vby_O7sWGkKMaV5bXiDGgFAoAzajST3OiaQsEV5ZIRYQQwYjQQURdUVhiUsURLUeSY5TvoeMidBf82h5jK1kULTTOsVpKC9HOYIuofFEsslSBFTw9_0Kmfh67_yEoJLnLKSa9OBmWDjzFAXc6Ca3VYlgSXq0rKRSiHSnp78Jk4Ny1U3_Krgx7QAby7Bpa_J5UvV0-PFxMilFrteTQ8Mu30j-Eff8-hEA</recordid><startdate>20160723</startdate><enddate>20160723</enddate><creator>Roberts, E.</creator><creator>Boden, L. A.</creator><creator>Ramsey, I. K.</creator><general>BMJ Publishing Group Limited</general><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20160723</creationdate><title>Factors that affect stabilisation times of canine spontaneous hypoadrenocorticism</title><author>Roberts, E. ; Boden, L. A. ; Ramsey, I. K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b4188-dc5f954e2de6ee542ba475baf2e859257416b6e41bae16f827d0e9bc1a7683043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adrenal gland</topic><topic>Adrenal Insufficiency - drug therapy</topic><topic>Adrenal Insufficiency - veterinary</topic><topic>Adrenocortical Hyperfunction - drug therapy</topic><topic>Adrenocortical Hyperfunction - veterinary</topic><topic>Animals</topic><topic>Dog Diseases - drug therapy</topic><topic>Dogs</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Therapy, Combination</topic><topic>Endocrinology</topic><topic>Female</topic><topic>Fludrocortisone - therapeutic use</topic><topic>Hormones</topic><topic>Hyperkalemia</topic><topic>Hyponatremia</topic><topic>Male</topic><topic>Potassium</topic><topic>Prednisolone - therapeutic use</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roberts, E.</creatorcontrib><creatorcontrib>Boden, L. A.</creatorcontrib><creatorcontrib>Ramsey, I. K.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Veterinary record</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roberts, E.</au><au>Boden, L. A.</au><au>Ramsey, I. K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Factors that affect stabilisation times of canine spontaneous hypoadrenocorticism</atitle><jtitle>Veterinary record</jtitle><addtitle>Vet Rec</addtitle><date>2016-07-23</date><risdate>2016</risdate><volume>179</volume><issue>4</issue><spage>98</spage><epage>98</epage><pages>98-98</pages><issn>0042-4900</issn><eissn>2042-7670</eissn><abstract>The objective of this retrospective study was to examine factors that may have affected the stabilisation times of 50 dogs with spontaneous hypoadrenocorticism that were being treated with fludrocortisone acetate, with particular emphasis on dosing frequency and the concurrent use of prednisolone. Stabilisation was defined as an absence of clinical signs with a sodium:potassium ratio &gt;27:1 and both electrolyte concentrations within a laboratory reference range. It was found that the median time till stabilisation was three months. The frequency of fludrocortisone treatment (once, twice or changed from once to twice a day) had no effect on the stabilisation time. The two groups of dogs that were started and stabilised on once a day or twice a day dosing had a median stabilisation time of two months. However, dogs that failed to stabilise on once a day dosing of fludrocortisone and were then changed onto twice a day dosing then stabilised a median of one month later. Concurrent use of prednisolone resulted in significantly faster stabilisation times. It was concluded that dogs with hypoadrenocorticism should be continued on prednisolone therapy until they are stabilised. If a dog is failing to stabilise on once a day fludrocortisone acetate, a change to twice a day administration could be considered.</abstract><cop>England</cop><pub>BMJ Publishing Group Limited</pub><pmid>27269282</pmid><doi>10.1136/vr.103663</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0042-4900
ispartof Veterinary record, 2016-07, Vol.179 (4), p.98-98
issn 0042-4900
2042-7670
language eng
recordid cdi_proquest_miscellaneous_1811884919
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adrenal gland
Adrenal Insufficiency - drug therapy
Adrenal Insufficiency - veterinary
Adrenocortical Hyperfunction - drug therapy
Adrenocortical Hyperfunction - veterinary
Animals
Dog Diseases - drug therapy
Dogs
Dose-Response Relationship, Drug
Drug Therapy, Combination
Endocrinology
Female
Fludrocortisone - therapeutic use
Hormones
Hyperkalemia
Hyponatremia
Male
Potassium
Prednisolone - therapeutic use
Retrospective Studies
Treatment Outcome
title Factors that affect stabilisation times of canine spontaneous hypoadrenocorticism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T01%3A49%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Factors%20that%20affect%20stabilisation%20times%20of%20canine%20spontaneous%20hypoadrenocorticism&rft.jtitle=Veterinary%20record&rft.au=Roberts,%20E.&rft.date=2016-07-23&rft.volume=179&rft.issue=4&rft.spage=98&rft.epage=98&rft.pages=98-98&rft.issn=0042-4900&rft.eissn=2042-7670&rft_id=info:doi/10.1136/vr.103663&rft_dat=%3Cproquest_cross%3E1807079618%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1806563251&rft_id=info:pmid/27269282&rfr_iscdi=true